Suppression of refractory recurrent ventricular tachycardia by transvenous rapid cardiac pacing and antiarrhythmic drugs. Report of seven cases.
D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001285:Atropine / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004077:Digoxin / Q000627:therapeutic use; D004562:Electrocardiography; D005260:Female; D006352:Heart Ventricles / Q000503:physiopathology; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D008012:Lidocaine / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010138:Pacemaker, Artificial; D010672:Phenytoin / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D013610:Tachycardia / Q000188:drug therapy / Q000628:therapy*; D014693:Ventricular Fibrillation / Q000188:drug therapy / Q000628:therapy*
D000889:Anti-Arrhythmia Agents; D004071:Digitalis Glycosides; D010672:Phenytoin; D004077:Digoxin; D001285:Atropine; D008012:Lidocaine; D011433:Propranolol; D011802:Quinidine; D011342:Procainamide; D007545:Isoproterenol